Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors.
暂无分享,去创建一个
A. Coxon | D. Whittington | A. Tasker | A. Polverino | J. Harmange | Julie Flynn | L. Berry | Y. Teffera | D. Choquette | D. Bauer | A. Long | M. Potashman | V. Berry | R. Zanon | Phillip M Roveto | J. Bready | T. DeMelfi | N. Doerr | J. Estrada | S. Kaufman | Sesha Neervannan | V. Patel | C. Starnes | S. Harriman | M. Schrag | K. Regal | D. La | M. Weiss | Danlin Chen | George Borg | R. Graceffa | Nicholas Doerr